Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Journal of Proteome Research
|
May 24, 2014
Targeted discovery and validation of plasma biomarkers of Parkinson's disease
Catherine Pan, Yong Zhou, Romel Dator, et al.
ACS Energy Letters
|
June 24, 2024
Boron-Silicon Alloy Nanoparticles as a Promising New Material in Lithium-Ion Battery Anodes
Gregory F Pach, Pashupati R Adhikari, Joseph Quinn, et al.
Phytochemical Analysis : PCA
|
April 14, 2020
Integration of mass spectral fingerprinting analysis with precursor ion (MS1) quantification for the characterisation of botanical extracts: application to extracts of Centella asiatica (L.) Urban
Armando Alcazar Magana, Kirsten Wright, Ashish Vaswani, et al.
Journal of Proteome Research
|
January 12, 2008
Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform
Sheng Pan, John Rush, Elaine R Peskind, et al.
Annals of Clinical and Translational Neurology
|
January 13, 2017
Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype
Christine A Cooper, Nimansha Jain, Michael D Gallagher, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 13, 2004
Absence of sustained hyperlactatemia in HIV-infected patients with risk factors for mitochondrial toxicity
David A Wohl, Christopher D Pilcher, Scott Evans, et al.
Neurology
|
May 12, 2025
The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical Trials
Christina B Young, Brenna Cholerton, Alena M Smith, et al.
Neurology
|
June 13, 2024
The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical Trials
Christina B Young, Brenna Cholerton, Alena M Smith, et al.
Archives of Neurology
|
December 17, 2003
Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?
Christopher M Clark, Sharon Xie, Jesse Chittams, et al.
The Lancet. Neurology
|
December 15, 2023
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Andrew McGarry, Shane Rosanbalm, Mika Leinonen, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Journal of Proteome Research
|
May 24, 2014
Targeted discovery and validation of plasma biomarkers of Parkinson's disease
Catherine Pan, Yong Zhou, Romel Dator, et al.
ACS Energy Letters
|
June 24, 2024
Boron-Silicon Alloy Nanoparticles as a Promising New Material in Lithium-Ion Battery Anodes
Gregory F Pach, Pashupati R Adhikari, Joseph Quinn, et al.
Phytochemical Analysis : PCA
|
April 14, 2020
Integration of mass spectral fingerprinting analysis with precursor ion (MS1) quantification for the characterisation of botanical extracts: application to extracts of Centella asiatica (L.) Urban
Armando Alcazar Magana, Kirsten Wright, Ashish Vaswani, et al.
Journal of Proteome Research
|
January 12, 2008
Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform
Sheng Pan, John Rush, Elaine R Peskind, et al.
Annals of Clinical and Translational Neurology
|
January 13, 2017
Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype
Christine A Cooper, Nimansha Jain, Michael D Gallagher, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 13, 2004
Absence of sustained hyperlactatemia in HIV-infected patients with risk factors for mitochondrial toxicity
David A Wohl, Christopher D Pilcher, Scott Evans, et al.
Neurology
|
May 12, 2025
The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical Trials
Christina B Young, Brenna Cholerton, Alena M Smith, et al.
Neurology
|
June 13, 2024
The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical Trials
Christina B Young, Brenna Cholerton, Alena M Smith, et al.
Archives of Neurology
|
December 17, 2003
Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?
Christopher M Clark, Sharon Xie, Jesse Chittams, et al.
The Lancet. Neurology
|
December 15, 2023
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Andrew McGarry, Shane Rosanbalm, Mika Leinonen, et al.
Page
of 6